对于患有COVID-19的年轻成年人的医院结果
Brian S Williams1,2,3, Thomas M Piasecki1,4, Michael C Fiore1,4
1Center for Tobacco Research and Intervention, University of Wisconsin School of Medicine and Public Health.
Global epidemiology
|August 5, 2024
概括
住院治疗COVID-19的年轻人经历了严重的疾病,癌症史增加了死亡风险. 接种疫苗可以防止严重的后果,如ICU入院.
科学领域:
- 传染性疾病 传染性疾病
- 公共卫生 公共卫生
- 流行病学 流行病学
背景情况:
- 老年人面临更高的COVID-19风险,但年轻人的结果不太了解.
- 年轻人经历了高的COVID-19感染率.
- 伴随性疾病加剧了COVID-19的严重后果.
研究的目的:
- 为了确定住院治疗COVID-19的年轻成年人的结果.
- 评估氧气使用率,死亡率,ICU入院率和输管率.
- 为了确定与年轻成年人不良COVID-19结果相关的因素.
主要方法:
- 这是一项回顾性队列研究,使用来自美国21个卫生系统的电子健康记录数据.
- 包括因COVID-19住院治疗的18-29岁的人 (2020年3月-2022年1月).
- 需要氧气的确诊有症状的病例;症状和无症状组之间的结果比较.
主要成果:
- 在9871名住院的年轻人中,有35%需要氧气.
- 死亡率: 2.6%; 住院于ICU: 27.7%; 输管: 15.8%. 死亡率: 2.6%; 住院于ICU: 27.7%; 输管: 15.8%.
- 癌症史增加了死亡几率 (2.1倍);疫苗接种减少了ICU几率 (>40%).
结论:
- 在需要氧气的住院年轻人中,COVID-19造成了显著的发病率和死亡率.
- 癌症史与更高的死亡风险有关.
- 疫苗接种证明了对严重的COVID-19疾病的保护作用.
更多相关视频
09:36Halogenated Agent Delivery in Porcine Model of Acute Respiratory Distress Syndrome via an Intensive Care Unit Type Device
Published on: September 24, 2020
2.7K
05:39Author Spotlight: A Non-Intubated Video-Assisted Thoracoscopic Surgery with Multimodal Analgesia and Sevoflurane Inhalation Anesthesia
Published on: May 26, 2023
1.5K
相关概念视频
01:30Pneumonia III: Complications and Assessment
193
Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
193
01:21Acute Respiratory Failure-II
192
Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
192
01:21Acute Respiratory Failure-I
184
Acute respiratory failure is a condition characterized by the inability of the lungs to perform their primary function: gas exchange. This failure leads to insufficient oxygen levels (hypoxemia) in the blood, elevated carbon dioxide levels (hypercapnia), or both, causing critical impairment in organ function.
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
184
01:29Acute Respiratory Failure-V
126
The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Ensure that patients are monitored continuously for their response to therapy, including changes in...
126
01:30Acute Respiratory Failure-III
167
Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without...
167
01:28Pneumonia IV: Management
314
The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
314